Close Menu

massively parallel semiconductor sequencing

Researchers at the Jackson Laboratory have tested an early version of the GenapSys sequencer and found it to have a very low mismatch error rate.

The startup is developing a semiconductor chip for single-molecule sequencing and plans to make the technology available to early-access customers by the end of this year.

Researchers from Life Technologies' Ion Torrent reported in Nature today that they have sequenced the genomes of three bacterial species and one human using their semiconductor sequencing method.

Using nuclear and mitochondrial genome sequencing and genotyping, researchers have garnered clues about the genetic diversity and structure within Tasmanian devil populations and gained insights into the contagious cancer threatening devils in the wild.

The grant winners, Angel Carracedo and Mark Pallen, each receive an Ion PGM sequencing platform. Three runners-up also will receive the sequencer.

With the launch of the Ion Torrent platform, Life Technologies said that it will award $1 million each to winners who can use the technology to improve upon results achieved internally in the first phase of the Life Grand Challenges Contest.

In another pact designed to broaden Roche 454 Life Sciences' portfolio, the firm will work with DNA Electronics to develop a low-cost, high-throughput DNA sequencer based on the UK company's ISFET technology.

The companies will enable CLC Bio's Genomics Workbench and Genomics Server systems to receive data from Ion Torrent's sequencer.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.